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Abstract. KARl is required for duplication of the Sac- 
charomyces cerevisiae  microtubule organizing center, 
the spindle pole body (SPB) (Rose, M.D., and G.R. 
Fink, 1987.  Cell. 48:1047-1060).  Suppressors of a karl 
allele defective for SPB duplication were isolated in 
two genes, CDC31 and DSK2 (Vallen, E.A., W.H., M. 
Winey, and M.D. Rose. 1994. Genetics.  137:407--422). 
To elucidate the role of DSK2 in SPB duplication, we 
cloned the gene and found it encodes a novel ubiquitin- 
like protein containing an NH2 terminus 36% identical 
to ubiquitin. The only other known yeast ubiquitin-like 
protein is encoded by the nucleotide excision repair 
gene RAD23 (Watkins, J.F., P. Sung, L. Prakash, and S. 
Prakash. 1993. Mol. Cell Bio. 13:7757-7765).  Unlike 
ubiquitin, the NHe-terminal domain of Dsk2p is not 
cleaved from the protein, indicating that Dsk2p is not 
conjugated to other proteins. Although the DSK2-1 
mutation alters a conserved residue in the Dsk2p ubiq- 
uitin-like domain, we detect no differences in Dsk2p or 
Cdc31p stability. Therefore, DSK2 does not act by in- 
terfering with ubiquitin-dependent protein degradation 
of these proteins. Although DSK2 is not essential, a 
strain deleted for both DSK2 and RAD23 is tempera- 
ture sensitive for growth due to a block in SPB duplica- 
tion. In addition, overexpression of DSK2 is toxic, and 
the DSK2-1 allele causes a block in SPB duplication. 
Therefore, DSK2 dosage is critical for SPB duplication. 
We determined that CDC31 gene function is down- 
stream of DSK2 and KARl. Dsk2p is a nuclear- 
enriched protein, and we propose that Dsk2p assists in 
Cdc31 assembly into the new SPB. 
T 
hE  eukaryotic microtubule  cytoskeleton  is  orga- 
nized and regulated by microtubule organizing cen- 
1  .L  ters (MTOC). The MTOC of the yeast Saccharo- 
myces  cerevisiae  (called the spindle pole body [SPB])  is 
similar to the centrosome of higher eukaryotes and is es- 
sential for microtubule-dependent processes such as mito- 
sis and meiosis (for review see Winey and Byers, 1993). In 
addition  to  their  similar  functions, the  centrosome  and 
SPB  are  subject to similar cell cycle regulation because 
they must be duplicated once per cell cycle to form a mi- 
totic spindle. However, despite the functional equivalence 
between the yeast SPB and the mammalian centrosome, 
the morphology between the structures is different. 
The SPB is a  trilaminar structure containing a  central 
plaque, which is physically embedded in the nuclear enve- 
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lope and inner and outer plaques that nucleate the nuclear 
and  cytoplasmic  microtubules,  respectively  (Byers  and 
Goetsch, 1974, 1975). A  membranous structure, the half- 
bridge, extends from the central plaque within the nuclear 
envelope. The entire SPB must faithfully duplicate once 
per cell cycle to form the poles of the mitotic spindle. At 
the beginning of the cell cycle, a satellite structure that is 
thought to be the precusor to the new SPB forms on the 
outer face of the half-bridge of the sole SPB. The next step 
is the formation of a new SPB, which is inserted into the 
nuclear envelope, resulting in adjacent SPBs connected by 
a complete bridge structure. The bridge is severed in a step 
that  involves  kinesin-like  motor  proteins  (Hoyt  et  al., 
1992; Roof et al., 1992), which act to separate the SPBs to 
opposite sides of the nucleus to form the poles of the mi- 
totic spindle. After mitosis and cytokinesis, the resulting 
daughter cells each contain a single SPB. Although SPB 
duplication once per cell cycle is essential for bipolar mi- 
totic spindle formation, very little is known about the reg- 
ulation of this essential process. 
The Karl protein, a component of the SPB (Vallen et 
al., 1992b; Spang et al., 1995), is essential for SPB duplica- 
tion during the cell cycle (Rose and Fink, 1987). To iden- 
tify additional proteins involved in SPB duplication, sup- 
pressors  of a  karl  allele  defective for SPB  duplication, 
karlA17, were isolated (Vallen et al.,  1992a,  1994).  The 
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Strain  Genotype  Source 
MS10 
MS1554 
MS2082 
MS2373 
MS2374 
MS2645 
MS2646 
MS3134 
MS3137 
MS3145 
MS3486 
MS3487 
MS3574 
MS3664 
MS3759 
MY424 
MY2259 
MY2260 
MY2261 
MY3316 
MY3317 
MY3320 
MY3321 
MY3324 
MY3328 
MY3329 
MY3334 
MY3335 
MY3516 
MY3522 
MY3523 
MY3545 
MY3573 
MY3587 
MY3588 
MY3589 
MY3592 
MY3602 
MY3603 
MY3604 
MY3714 
MY3715 
MY3740 
MY3741 
MY3742 
MY3743 
MY3752 
MY3753 
MY3754 
MY3755 
MY3756 
MY3757 
MY3758 
MY3759 
MY4240 
MATa ura3-52 leu2-3,112 ade2-101 
MATa ura3-521eu2-3,112 ade2-101 his3A200 
MATer ura3-52 1eu2-3,112 ade2-101 kar1A17 
MATa ura3-52 Ieu2-3,112 trpl A1 karlA17;  [pMR76] 
MATct ura3-52 leu2-3112 trplA1 ade2-101 karl A17; [pMR76] 
MATa ura3-52 1eu2-3,112 ade2-101 karlzl2,  DSK2-1 
MATer ura3-52 1eu2-3,112 trpl A1 ade2-101 karl A2 DSK2-1 
MATer ura3-52 1eu2-3,112 ade2-101 karl A17 DSK2-1 
MATer ura3-52 1eu2-3,112 ade2-101 karl A17 CDC31-16 
MATer ura3-52 1eu2-3,112 ade2-101 karl A17 DSK2-1 
MATa ura3-52 ade2-101 lys2-801 trpl A1 CDC31-16; [pMR2745] 
MATa ura3-52 ade2-101 lys2-801 trpl A1 CDC31-16; [pMR1872] 
MATa ura3-52 leu2-3,112 ade2-101 dsk2A::LEU2 
MATa ura3-52 leu2-3,112 trp  l A1 karl A17 dsk2 A  :  :  LEU2 
MATa ura3-52 Ieu2-3,112 ade2-101 his3A200 DSK2-1 
MATa ura3-52 Ieu2,3-112 his4-519 adel-lO0 
MATa ura3 trpl his7 cdc31-1 
MATer ura3 leu2 trpl ade2 cdc31-2 
MATer ura3 ade met2 cdc31-5 
MATa ura3-52 1eu2,3-112 his4-519 adel-lO0;  [pMR2745] 
MATa ura3-52 leu2,3-112 his4-519 adel-lO0;  [pMR2757] 
MATer ura3 trpl his7 cdc31-1; [pMR1872] 
MATer ura3 trpl his7 cdc31-1; [pMR2745] 
MATa ura3-52 1eu2,3-112 his4-519 adel-lO0;  [pMR1872] 
MATer ura3 ade met2 cdc31-5; [pMR1872] 
MATer ura3 ade met2 cdc31-5; [pMR2745] 
MATer ura3 leu2 trpl ade2 cdc31-5; [pMR2745] 
MATa ura3 leu2 trpl ade2 cdc31-2; [pMR1872] 
MATalMATet lys2-801/+  trpl A63 leu2/leu2 ura3-52/ura3-52; [pMR613] 
MATa/MATet lys2-801/+  trpl A63/trp1A63 leu2/leu2 ura3-52/ura3-52; [pMR2905] 
MATa/MATct lys2-801/+ trp1A63 leu2/leu2 ura3-52/ura3-52; [pMR2906] 
MATer ura3-52 lys2 ade2-1 leu2A his3A200 rad23A::URA3 
MATa ura3-52 leu2 his3A200 ade2 dsk2A::LEU2 rad23A::URA3 
MATer ura3-52 leu2 his3 ade2 rad23A:: URA3 
MATa ura3-52 trpl ade2 his3 dsk2A::LEU2 
MATa ura3-52 leu ade2 
MATer ura3-52 leu2 his3A200 ade2 dsk2A::LEU2 rad23A 
MATct ura3-52 leu2 his3A200 ade2 dsk2A::LEU2 rad23A; [pMR2032] 
MATa ura3-52, leu2 his3A200 ade2 dsk2 A::LEU2 rad23A; [pMR2223] 
MATer ura3-52 leu2 his3A200 ade2 dsk2A::LEU2 rad23A; [pMR1868] 
MATer ura3-52 1eu2,3-112 his3 ade2 rad23A karl A17; [pMR76] 
MATer ura3-52 1eu2,3-112 his3 ade2 rad23A karl A17 
MATa ura3-52 leu2,3-112 ade2-101 karlA17 DSK2+ RAD23+ 
MATct ura3-52 1eu2,3-112 lys trp1A63 ade2-101 karlA17 dsk2A::LEU2 rad23A 
MATe~ ura3-52 1eu2,3-112 lys his ade2-101 karlA17 DSK2+  rad23A 
MATa ura3-52 1eu2,3-112 ade 2-101 his kar1A17 dsk2A::LEU2 RAD23+ 
MATa ura3-52 leu2,3-112 ade2-101 karlA17 DSK2 + RAD23+;  [pMR2223] 
MATa ura3-52 Ieu2,3-112 ade2-101 karlAI7 DSK2 + RAD23+ ; [pMR2032] 
MATa ura3-52 leu2,3-112 ade2-101 karlA17 DSK2 + RAD23 +; [pMR2745] 
MATa ura3-52 leu2,3-112 ade2-101 kar1A17 DSK2+ RAD23+ ; [pMR1868] 
MATer ura3-52 leu2,3-112 lys trpl A63 ade2-101 kar1A17 dsk2A::LEU2 rad23A; [pMR2223] 
MATer ura3-52 leu2,3-112 lys trp1A63 ade2-101 kar1A17 dsk2A::LEU2 rad23A; [pMR2032] 
MATct ura3-521eu2,3-112 lys trp1A63 ade2-101 karlA17 dsk2A::LEU2 rad23A; [pMR2745] 
MATcx ura3-52 1eu2,3-112 lys trp1A63 ade2-101 karlA17 dsk2A::LEU2 rad23A; [pMR1868] 
MATaJMATet ura3-52/ura3-52 leu2/leu2 his3/HIS3 lys2/LYS2 TRP1/trp  l A1 ade2/ade2 
rad23A/rad23A:: URA3 dsk2A::LEU2/dsk2 A::LEU2 
All strains designated MS are isogenic with strain $288c. Unless noted otherwise, all strains were constructed for this study or are Rose lab strains. 
*Vallen et al., 1992a. 
*Vallen et al., 1994. 
~B. Byers, University of Washington, Seattle, WA. 
IIs. Prakash, University of Texas, Galveston, TX. 
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groups,  CDC31  and  DSK2.  CDC31  encodes a  calcium- 
binding protein (Baum et al., 1986) most homologous to 
centrin/caltractin, a component of the Chlamydomonas re- 
inhardtii  MTOC  (Huang et al.,  1988a,b;  Salisbury et al., 
1988).  This  protein  is  a  conserved  component  of  the 
MTOC  in  yeast  (Spang  et  al.,  1993;  Biggins  and  Rose, 
1994)  and  other  eukaryotic  organisms  (e.g.,  Lee  and 
Huang,  1993).  The  KARl  and  CDC31  genes  display  a 
number of genetic interactions (Vallen et al.,  1994), and 
the protein products interact directly in vitro (Biggins and 
Rose, 1994; Spang et al., 1995). Although Cdc31p localizes 
to the  SPB  in  wild-type cells, it was  mislocalized in  the 
karlA17 mutant  (Biggins  and  Rose,  1994;  Spang  et  al., 
1995). Suppressor alleles of CDC31 restored SPB localiza- 
tion of Cdc31p, suggesting that Karlp's mitotic function is 
to recruit and maintain Cdc31p at the SPB. Since some of 
the  suppressors  completely bypass  the  requirement  for 
KARl, suppression cannot be due to an altered interaction 
between Cdc31p and Karlp. Therefore, it is most likely 
that the CDC31 suppressors have an increased interaction 
with another SPB component and no longer require Karlp 
for SPB localization. 
Two independent alleles of DSK2 isolated as karlA17 
suppressors  also  bypass  the  essential  function of KARl 
(Vallen et al., 1994). The Dsk2p suppressor proteins might 
directly interact with Cdc31p to localize it to the SPB in a 
karl deletion strain, or they might act indirectly to bypass 
the  KARl  function. To elucidate the  role of the DSK2 
suppressors  in  SPB  duplication,  we  cloned  DSK2  and 
found it encodes a novel ubiquitin-like protein. 
Ubiquitin is a highly conserved essential 76-amino acid 
protein that is posttranslationally conjugated to substrates 
to modify their function (for reviews see Jentsch,  1992; 
Ciechanover, 1994).  Ubiquitin is  synthesized as  a  fusion 
protein in which the first 76 amino acids encode ubiquitin 
and the remainder encodes either other ubiquitins or un- 
related proteins that are often involved in protein synthe- 
sis.  Cellular hydrolases (El enzymes) cleave the primary 
translation product to generate free ubiquitin, which can then 
be conjugated to substrate proteins by ubiquitin-conjugating 
enzymes (E2 enzymes). Substrates can be monoubiquiti- 
nated, which may change function, or polyubiquitinated, 
which targets them for degradation via the proteasome. 
Conjugation  sometimes requires  the  function of a  third 
protein (E3 ligase). 
The ubiquitin-like proteins are a growing family of pro- 
teins that contain NH2-terminal domains homologous but 
not  identical  to  true ubiquitin.  Although  these  proteins 
have been identified in many organisms, the functions of 
almost all of them are unknown. One of the major classes 
of ubiquitin-like genes is involved in DNA repair and in- 
cludes the yeast gene RAD23 (Watkins et al., 1993) and its 
human  homologues,  the  XP-C  genes  (Masutani  et  al., 
1994). RAD23 was the first ubiquitin-like gene identified 
in yeast and was originally isolated in a screen for UV-sen- 
sitive mutants. A  rad23A does not exhibit growth defects 
but displays an increased sensitivity to UV light (Watkins 
et al., 1993). Rad23p is a highly stable nuclear protein, and 
its function in DNA repair may be to facilitate the interac- 
tion between the nucleotide excision repair protein Radl4 
and the TFIIH subunit of RNA polymerase (Guzder et al., 
1995). Here we show that DSK2 also encodes a ubiquitin- 
like protein in which the first 76 amino acids are signifi- 
cantly homologous to ubiquitin and the remainder of the 
protein does not exhibit homology to any known proteins. 
In  addition,  we  show that  DSK2+  gene  function is  re- 
quired with RAD23 function for SPB duplication, and we 
present models for the potential role of the DSK2+ gene. 
Materials and Methods 
Microbial Techniques and Yeast Strain Constructions 
Yeast media and genetic and microbial techniques were essentially as de- 
scribed in Rose et al.  (1990).  Bacterial  media was as described in Sam- 
brook et al. (1989),  and bacterial strains XL1-Blue and BL21  were used 
for all bacterial manipulations. 5-fluoroorotic acid  (5-FOA) was used to 
select Ura- segregants as described by Boeke et al. (1984). 
All  yeast strains used are  listed  in Table  I. Yeast strains were con- 
structed by standard genetic techniques. Diploids were selected on the ap- 
propriate selective  media at 23°C and subsequently sporulated at 23°C. In 
crosses containing  the  karlzal7  allele,  a  KARl+  URA3  plasmid  was 
present to prevent increased  ploidy before the cross. After the tetrads 
were dissected, Ura- derivatives were selected on 5-FOA (Boeke et al., 
1984). 
A  two-step gene replacement method (Rothstein,  1991) was used to 
construct a dsk2A strain (MS3574).  Plasmid pMR2860 was cut with MscI 
and transformed into haploid (MS10)  and diploid (MS810) strains. Trans- 
formants were selected on synthetic complete (SC)-leu media at 23°C and 
subsequently streaked onto 5-FOA to select -Ura recombinants. To assay 
for the presence of the dsk2A, PCR analysis was performed with a primer 
within the LEU2 gene (5' ACA/CCA/TAC/CCA/TCG/TCT 3'; courtesy 
of Scott Holmes, Princeton University, N  J) and a DSK2 primer (5' GGG/ 
GAG/ACC/TTA/TTT 3'). PCR  analysis confirmed the presence of the 
dsk2A in the haploid strain, indicating  that DSK2 is not required for cell 
viability.  The deletion was also confirmed by Western blotting of dsk2A 
strain (MS3574) extract with anti-Dsk2p antibodies that confirmed the ab- 
sence of Dsk2p. 
A  DSK2-1  KARl+  strain  was  constructed  by  crossing a  DSK2-1 
karlA2 strain (MS2646)  to a DSK2+ KARl + strain (MS1554). A nonpa- 
rental ditype from this cross was backcrossed to confirm the genotype as 
DSK2-1  KARl+.  To generate a  dsk2A  rad23A  strain,  a  rad23A  strain 
(MY3545)  marked with URA3 was crossed to a dsk2A strain (MS3574) 
marked  with  LEU2.  To  allow  further genetic  manipulations with  the 
URA3 marker, a Ura- dsk2A rad23A  strain (MY3592)  was generated by 
selecting  5-FOA-resistant segregants of one of the Ura+  Leu+ spores. 
This was possible because the rad23A marked with URA3 was flanked by 
direct repeats (Watkins et al., 1993). To generate a dsk2A karlA17 strain, 
a DSK2+ karlA17 strain (MS2374) was crossed to a dsk2A KARl + strain 
(MS3574).  To  generate  a  CDC31-16  dsk2A  karlzal7  strain,  a  dsk2A 
karlD17  strain  (MS3664)  was crossed  to  a  CDC31-16  karlA17  strain 
(MS3137).  A  rad23A  karlAl7 strain was generated by crossing a dsk2A 
rad23A  strain  (MY3592)  to a  karlA17 strain  (MS2373).  To generate a 
dsk2A  rad23A  karlA17  strain,  a  rad23A  karlA17  strain  (MY3714)  was 
crossed to a dsk2A karlA17 strain (MS3664). 
To  test  suppression  of  rad23A  dsk2A  temperature  sensitivity  by 
CDC31-16 and high copy CDC31 +, plasmids pMR2023  (2 Ixm, CDC31 +), 
pMR2223  (2 Ixm, CDC31-16),  and pMR1868 (pRS416;  Sikorski and Hie- 
ter,  1989) were transformed into MY3592  to generate strains MY3602 
(pMR2032),  MY3603  (pMR2223),  and MY3604  (pMR1868).  Serial  dilu- 
tions of the transformants were tested for growth at 37°C and determined 
that CDC31-16  and high copy CDC31+  suppress the temperature sensi- 
tivity  of the rad23A  dsk2A  strain. Strains MY3752-MY3763  were gener- 
ated and tested for growth at 33  °, 35 °, and 37°C the same way by trans- 
forming MY3741. 
Growth curves on strains MY3522  and  MY3523  were performed by 
growing them in SC-ura media with 2% raffinose at 30°C to early logarith- 
mic phase. The cultures were split in half,  and galactose or glucose was 
added to each half to 2% final concentration. Aliquots were taken every 
hour upon galactose or glucose addition, and serial dilutions were plated 
on SC-ura glucose plates. The viability was calculated as the number of vi- 
able cells per ml at each time point. Growth curves on strains MY3587, 
MY3588,  MY3589,  and MY3592  were performed the same way, except 
the strains were grown at 30°C in yeast extract/peptone/dextrose (YPD) 
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vested every hour and plated on YPD plates at 30°C. 
Plasmid Constructions 
All restriction enzymes used in this study were obtained from New En- 
gland Biolabs (Beverly, MA)  and were  used according to  the supplier 
specifications. All PCR primers were synthesized at the Princeton Univer- 
sity sequencing facility. All cloning techniques were performed according 
to Sambrook et al. (1989). 
DSK2  subclones  were  obtained  by  isolating  restriction  fragments 
(shown in Fig. 1 A) from the smallest suppressing plasmid (pMR3165) and 
by ligating them into pRS416 (Sikorski and Hieter, 1989)  or YCp50 (Rose 
et al., 1987).  To determine which open reading frame (ORF) suppressed 
karlA17, the URA3 gene was isolated on a 1.1-kb HIII fragment and filled 
in with Klenow. This was ligated into pMR2719, which had been linear- 
ized with Ncol and filled in with Klenow to generate pMR2718 that dis- 
rupts ORF2 (shown in Fig. 1 B). 
Glutathione-S-transferase (GST)-Dsk2p bacterial expression plasmids 
were generated by PCR amplification of the DSK2+ and DSK2-1 genes 
using primers 5'GGC/AAA/TAA/GAC/GGA/TCC/AAG/ACA/CCG 3' 
and 5' GAT/AT17ATT/GAT/GGA/TCC/ATG/TAA/TAC  3'. These prim- 
ers have BamHI sites engineered to allow subsequent digestion and ligation 
of the PCR products such that the entire DSK2 gene will  be expressed. 
PCR  was  performed  on  plasmids pMR2745  (DSK2-1)  and  pMR2757 
(DSK2+), and the 1.8-kb product was digested with BamHI and ligated 
into the BamHI site of pGEX-KT (courtesy of Steve Haney, Princeton 
University,  N J)  to  generate  pMR2863  (GST-Dsk2-1p)  and  pMR2862 
(GST-Dsk2p). These plasmids were  transformed into BL21  to generate 
strains MR2865  (pMR2862) and MR2863 (pMR2863), which were  used 
for Dsk2p expression and purification to generate antibodies. To generate 
GST-Dsk2p  ubiquitin-like  domain fusions, the  first  80  amino acids  of 
Dsk2p were cloned into the pGEX-2T vector (courtesy of Steve Haney). 
PCR was performed on pMR2757 (DSK2+) and pMR2745 (DSK2-1) us- 
ing  primers  5'GGC/AAA/TAA/GAC/GGA/TCC/AAG/ACA/CCG  3' 
and 5' GGG/GAA/TCC/GGC/GGT/TTG/TGG/TTT/GGG 3'. The 275- 
bp amplified DNA product was digested with BamHI and EcoRI  (sites 
were  engineered into the PCR primers) and cloned into pGEX-2T cut 
with  BamHI/EcoRI  (courtesy  of  Steve  Haney)  to  generate  plasmids 
pMR2908  (GST-Dsk2p  ubiquitin-like  domain)  and  pMR2909  (GST- 
Dsk2-1p ubiquitin-like domain). These plasmids were  transformed into 
BL21 to generate strains MR2910 (pMR2908) and MR2911 (pMR2909) 
for expression and purification of the recombinant proteins. 
The full-length DSK2+  and DSK2-1  PCR products described above 
were cloned into centromere-based vector pRS414 (Sikorski and Hieter, 
1989)  at the BamHI site and checked for suppression of karlA17 to con- 
firm the presence or absence of the DSK2-1  mutation. These plasmids, 
pMR2838 (DSK2+) and pMR2859 (DSK2-1), were used to construct ga- 
lactose-inducible versions of the DSK2 gene. The DSK2 genes were iso- 
lated by digestion with BamHI and ligated into pMR613 at the BamHI 
site.  The  resulting  plasmids,  pMR2873  (DSK2-1)  and  pMR2872 
(DSK2+), are 2-~m, URA3 plasmids with DSK2 under the control of the 
GALl promoter (Yocum et al., 1984).  Centromere-based plasmids were 
constructed by isolating the PGAL-DSK2 EcoRI/SalI 2-kb fragment from 
pMR2873  and pMR2872 and ligating it into pMR1868 cut with EcoRI/ 
XhoI. This generated plasmids pMR2905 (PGaL-DSK2+) and pMR2906 
(PcAL-DSK2-1). All  experiments reported  in  this paper  used the  cen- 
tromere-based versions of PGAL-DSK2. 
DSK2 Deletion and Integration  Plasmids 
To generate a two-step DSK2 gene replacement plasmid, a series of plas- 
mids  were  constructed.  First,  the  DSK2+  gene  was  removed  from 
pMR2757 by digestion with XbaI and BamHI, leaving the 3' flanking 540 
bp of the DSK2 gene on the plasmid. This was ligated with the LEU2+ 
gene isolated as a 2-kb XbaI/BamHI fragment to generate pMR2819. This 
plasmid was then digested with BamHI, which was ligated with 430 bp of 
the 5' flanking region of the DSK2 gene (which was PCR amplified using 
primers 5'  GTC/GGA/TCC/GAT/CCG/TCT/TAT/TfG/CCT/CTC/G 3' 
and 5'  CAA/GAA/TCC/CCG/TAG/C 3').  This generated pMR2831,  a 
centromere-based URA3 plasmid containing the LEU2 gene flanked by 3' 
and 5' DSK2 sequence, pMR2831 was digested with BglII/SpeI to remove 
the centromere, the ends were filled in with Klenow, and the vector was 
religated to obtain pMR2860, a vector that can be used for two-step gene 
replacement of DSK2. 
To test linkage between the library clones and the DSK2-1 suppressor, 
a 2.5-kb XhoI/HIII fragment that suppressed karlA17 was cloned into the 
LEU2+ integrating vector pRS405 (Sikorski and Hieter, 1989)  to gener- 
ate pMR3161. The plasmid was linearized with NcoI to direct integration 
into a karlA17 DSK2+ strain (MS2373). The integration was confirmed 
by Southern analysis. Since the karlA17 allele has a tendency to diploidize 
(Vallen et al., 1992a), the strain MS2373 contained a KARl +, URA3 plas- 
mid to ensure spore viability during a cross. After dissection and selection 
on 5-FOA, the spores were tested for temperature resistance to follow the 
suppression of the karlA17  allele. Six tetrads segregated 4:0 for tempera- 
ture resistance, indicating that the suppressing activity present on the inte- 
grating DNA  corresponded to  the DSK2.1  locus. To  confirm this, the 
spores from one tetrad were  backcrossed to  a  karlA17,  DSK2+  strain 
(MS2372)  and dissected. Temperature resistance of these spores segre- 
gated 2:2, indicating that the authentic DSK2-1 locus had been cloned. 
DSK2-1 Library Construction 
One liter of strain MS3145 (DSK2-1, karlA17)  was grown to OD 600 of 
1.7 in YPD and harvested to isolate genomic DNA as described in Gaber 
et al.  (1990). To construct the library, Sau3A partial enzyme digestions 
were performed as described in Rose and Broach (1991) and subsequently 
fractionated on 10-40% sucrose gradients as described in Current Proto- 
cols in Molecular Biology (Ausubel et al., 1994). The 5-10-kb and 10-20- 
kb  fractions  from  the  gradients  were  pooled  and  ligated  into  vector 
pRS414  (Sikorski and Hieter,  1989)  at the BamHI site as described  in 
Rose and Broach (1991).  To amplify the library, ligations were electropo- 
rated into strain XL1-Blue (Bullock et al., 1987)  and plated on LB-amp 
plates. At least 35,000 colonies were pooled and DNA was isolated (Sam- 
brook  et al., 1989).  Random screening of 20 plasmids indicated at least 
60% of the plasmids contain inserts with an average size of 10 kb, repre- 
senting a library of at least 14 genomes. The library reference numbers are 
pMR3173-3178. 
DSK2 Cloning, Mapping, and Sequencing 
The  DSK2-1  library  was  transformed  into  karlA17  (MS2082),  and 
~50,000  transformants  (representing  ~14  genomic  equivalents)  were 
grown at 23°C and subsequently replica printed to 37°C.  17 temperature- 
resistant colonies were isolated, retested, and checked for plasmid-linkage 
by selecting segregants that lost the plasmid by growth on 5-FOA. All 17 
strains depended on the plasmid to be temperature resistant, so the plas- 
mids were isolated from yeast by the method of Hoffman and Winston 
(1987), amplified in bacteria, and retransformed into karlA17 (MS2082). 
All  17  plasmids  once  again  conferred  temperature  resistance  upon 
karlA17.  Restriction mapping indicated the 17 plasmids represented  11 
unique plasmids, pMR3162-3172,  that  contained common internal  1.3- 
and 4.2-kb RI/HIII fragments. The outer regions were mapped, and the 
smallest clone, pMR3165, contained ~7 kb as shown in Fig. 1 A. 
To localize the DSK2 gene, the subclones shown in Fig. 1 A  were con- 
structed, transformed into karlA17 (MS2082), and tested for temperature 
sensitivity. We found that the 4.2-kb RI/HIII subclone consistently sup- 
pressed karlA17 to levels comparable to the DSK2-1 suppressor. Smaller 
subclones that were constructed (shown in Fig. 1 A) from this 4.2-kb plas- 
mid still suppressed karlA17,  but resulted in reduced colony sizes at both 
23  ° and 37°C. Therefore, the entire 4.2-kb EcoRI/HIII subclone (pMR3153) 
that suppressed kar1A17 was sequenced. Decreased colony size observed 
when the 4.2-kb fragment was further subcloned may be due to toxicity of 
expressing the NH2 terminus of the adjacent gene (Wolfe, D., and R. Keil, 
personal communication). 
Both strands of the 4.2-kb DSK2 clone were sequenced and can be ac- 
cessed through EMBL/GenBank/DDBJ  accession number L40587. The 
1,852 bp that include the DSK2+ gene are shown in this publication. We 
named the gene adjacent to DSK2 the DAG1 gene (DSK2 adjacent gene), 
and later learned it corresponds to the ZZZ1 gene that is involved in re- 
sponse to anesthesia (Wolfe, D., and R. Keil, personal communication). 
This gene is also entered in GenBank as the BULl gene with accession 
number D50083. To facilitate DSK2 sequencing, the 4.2-kb subclone was 
excised from  pMR3165  using HIII  and  ligated  into  Bluescript vectors 
(Stratagene, La Jolla, CA) to allow exonuclease III digestions to be per- 
formed by the method of Clark and Henikoff (1994).  The exonuclease de- 
letions from clones pMR2833 and pMR2834 were then sequenced using 
T7  or T3  primers (Princeton  University) complementary to  the vector 
DNA with the Sequenase version 2.0 kit supplied by United States Bio- 
chemical Corp.  (Cleveland, OH)  according to double-strand sequencing 
method provided by the company. Gaps that remained were sequenced 
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were performed using the sequence analysis software package by Genetics 
Computer Group, Inc. (Madison, WI). 
To physically map DSK2, a  300-bp PstI fragment was labeled by the 
random primer method of Feinberg and Vogelstein (1983) and used to hy- 
bridize to lambda prime clone filters provided by Linda Riles (Washing- 
ton University School of Medicine, St. Louis, MO) according to the pro- 
vided protocol. 
Since the DSK2-1 mutant allele was cloned and sequenced first, the 
wild-type DSK2+ gene and the DSK2-2 suppressor were recovered by the 
gap-repair technique (Orr-Weaver et al., 1983). DSK2 was removed from 
a  centromere-based  plasmid containing the DSK2-1  gene  by digestion 
with XbaI and Mcsl. The gapped plasmid was transformed into karlA17 
strains  containing  either  the  wild-type  DSK2+  (MS2082)  or  DSK2-2 
(MS3134) alleles. DNA from the yeast transformants was isolated, and re- 
striction analysis was performed to confirm that the gap was repaired. The 
gap-repaired plasmids were then transformed into karlA17 (MS2082) to 
test for suppression of the temperature sensitivity. Plasmids isolated from 
the wild-type DSK2+ strain (MS2082) did not suppress the karlA17 de- 
fect, indicating that the wild-type DSK2+ gene was recovered. Plasmids 
isolated from the DSK2-2 strain (MS3134) suppressed kar1A17, indicating 
that the DSK2-2 suppressor was recovered. The DSK2 gene on these plas- 
mids was sequenced, and we found a single base pair difference between 
the DSK2-1 gene and the DSK2+ gene: codon 69 is changed from a TAT 
in DSK2-1 to a  CAT in DSK2+. The DSK2-2 suppressor contained the 
same mutation as the DSK2-1 suppressor. 
Immunological Techniques 
Antibodies against bacterially expressed Dsk2p were generated in two fe- 
male New Zealand White rabbits at the Princeton University Animal Fa- 
cility.  GST-Dsk2p  protein  (strain  MR2865)  was  purified  according  to 
Smith and Johnson (1988) in the presence of protease inhibitors (chymo- 
statin, leupeptin, aprotinin, pepstatin A, and AEBSF at 2 mg/ml final con- 
centration and PMSF at 1 mM final concentration). AEBSF was obtained 
from Calbiochem-Novabiochem Corp. (La Jolla, CA), and all other pro- 
tease  inhibitors were  from  Sigma Chemical Co.  (St.  Louis, MO).  The 
GST-Dsk2p was eluted from the glutathione beads by competition with 10 
mM glutathione (Sigma Chemical Co.) for 60 min at room temperature. 
The thrombin-cleaved protein was separated on a  10% denaturing poly- 
acrylamide gel  and transferred  to  nitrocellulose  (Schleicher  &  Schuell, 
Keene, NH), and the band containing Dsk2p was excised. The nitrocellu- 
lose  strip, which contained at  least 0.5  mg of Dsk2p, was dissolved in 
DMSO.  This mixture was emulsified with  Freund's complete  adjuvant 
(Sigma  Chemical  Co.)  and  injected  subcutaneously. Boosts were  per- 
formed monthly with at least 100 mg of this same mixture emulsified in 
Freund's incomplete adjuvant (Sigma Chemical Co.). 
To purify full-length and NHE-terminal Dsk2p antibodies, GST-Dsk2p 
and GST-ub-like domain recombinant protein were purified as described 
above, except the proteins were not thrombin cleaved. Approximately 0.5 
mg of the soluble proteins were conjugated to Sulfo-link resin using the 
Sulfo-link kit (Pierce Chemical Co., Rockford, IL) according to the manu- 
facturer's specifications. 
Yeast extracts for Western blotting were prepared according to Ohashi 
et al. (1982). For Western blotting, proteins were separated on denaturing 
polyacrylamide gels, transferred to nitrocellulose (Schleicher & Schuell), 
and then Western blotted as described in Biggins and Rose (1994). Affin- 
ity purified anti-Dsk2p antibodies were used at a 1:1,000 dilution, affinity- 
purified anti-Cdc31p antibodies (Biggins and Rose, 1994) were used at a 1: 
500 dilution, and anti-ubiquitin antibodies (East Acres Biologicals, South- 
bridge, MA) were used at a  1:1,000  dilution. Secondary antibodies were 
obtained from Amersham Corp. (Arlington Heights, IL) and used at a 1: 
2,000  dilution  followed  by  enhanced  chemiluminescence according  to 
manufacturer's directions. For competition experiments, various amounts 
of purified GST-Dsk2p ubiquitin-like domain recombinant protein were 
included during the primary incubations. 
For the PeAL shut-off  experiments, strains MY3520 (pMR2903), MY3521 
(pMR2904),  MY3522  (pMR2905),  MY3523  (pMR2906),  and  MY3516 
(pMR613) were grown overnight at 30°C in SC-ura media with 2% raffi- 
nose to early logarithmic phase. Galactose was added to 2% final concen- 
tration for 2 h to induce the expression of the Dsk2 proteins. Glucose was 
then added to 2% final concentration to repress synthesis of the Dsk2 pro- 
teins. Equal volumes of ceils were harvested at 0, 3, 7, and 9 h after glu- 
cose addition, and protein extracts were prepared and separated on a de- 
naturing polyacrylamide gel. After transfer to nitrocellulose, a  Western 
blot was performed to detect the levels of Dsk2p. As an internal loading 
control, the blots were also probed with anti-Kar2p antibodies (Rose et 
al., 1989). 
Partially purified SPBs were prepared in collaboration with Dr. Mark 
Winey (University of Colorado, Boulder, CO) under the direction of Dr. 
Mike Rout (Rockefeller University, New York) according to the protocol 
of Rout and Kilmartin (1990). Briefly, spheroplasts were made from Sac- 
charomyces uvarum and lysed. A  crude nuclear pellet was loaded onto a 
gradient of layers 2.0, 2.1, and 2.3 M sucrose-polyvinylpyrolidone. The nu- 
clei from the 2.1/2.3 fraction were collected and lysed, and SPBs were sub- 
sequently enriched on a step sucrose gradient. The steps in this gradient 
are: the sample layer, 1.75 M, 2 M, 2.25 M, and 2.5 M  sucrose, all as de- 
scribed in Rout and Kilmartin (1990). 
Pulse-chase Experiments 
Pulse-chase  experiments  were  performed  essentially  as  described  by 
Gammie et al. (1995) on 4.50D units of strains MS1554 and MS3759. The 
35S-translabel was added for a pulse of 5 min at 30°C, and 0.5-ml aliquots 
of cells were removed at 0, 2, 4, 8, and 24 h during the chase. The labeled 
cells were lysed with glass beads by vortexing in buffer (50 mM Tris-C1, 
pH 7.4, 100 mM NaC1, 2 mM EDTA, 1 mM PMSF, 1% SDS), boiled for 4 
min, and then spun for 10 min in a microfuge. The supernatant was diluted 
fourfold with  buffer  (60  mM Tris-C1, pH  7.4,  6  mM EDTA,  190  mM 
NaCL, 1 mM PMSF, 0.1% Triton X-100) to a final SDS concentration of 
0.2%. Two ml of anti-Dsk2p or anti-Cdc31p antibodies were added over- 
night at 4°C.  Protein  A-Sepharose  (Pharmacia Fine  Chemicals, Piscat- 
away, NJ) was added for 2  h  at room temperature, and the beads were 
then washed twice each with high salt wash (1% Triton X-100, 0.2% SDS, 
0.5 M NaC1, 5 mM EDTA, and 50 mM Tris, pH 7.4), IP wash (1% Triton 
X-100, 0.2% SDS, 5 mM EDTA, and 0.15 M NaC1), and then detergent- 
free wash. SDS sample buffer (Biggins and Rose, 1994)  was added to the 
beads, and the immunoprecipitates were separated on denaturing poly- 
acrylamide gels, fixed in Amplify (Amersham Corp.)  for 30 rain, dried, 
and autoradiographed. 
Microscopy 
Indirect immunofluorescence using formaldehyde fixation of intact cells 
was performed as described by Rose et al. (1990), and indirect immunoflu- 
orescence using MeOH, acetone fixation of spheroplasts, was performed 
as described by Rout and Kilmartin (1990). Two different methods of fixa- 
tion were used because the SPB  antibodies do not stain formaldehyde- 
fixed cells, and because tubulin antibodies do not stain the methanol, ace- 
tone-fixed  cells  (Rout  and  Kilmartin,  1990;  Biggins and  Rose,  1994). 
Formaldehyde fixation was for 1 h at 23°C for all strains. Strains MY3516, 
MY3522, and MY3523 were grown to early logarithmic phase in SC-ura 
media containing 2% raffinose, and then galactose was added to 2% final 
concentration  for  10  h  and  harvested for  immunofluorescence. Strains 
MY3587, MY3588, MY3589, and MY3573 were grown to early logarith- 
mic phase in YPD media at 30°C, shifted to 37°C for 6 h, and harvested. 
Strains MS10, MS3574, and MS3759 were grown to mid-logarithmic phase 
in  YPD  media and harvested. Affinity purified  anti-Cdc31p antibodies 
(Biggins and Rose, 1994) were used at a 1:1,000 dilution, and affinity-puri- 
fied anti-Dsk2p antibodies were used at a 1:100 dilution. Anti-90-kD anti- 
bodies and rat anti-tubulin antibodies were used at a  1:500  dilution and 
were  the  generous gift  of John  Kilmartin  (Medical  Research Council, 
Cambridge, UK). Rabbit anti-tubulin antibodies were also used at a dilu- 
tion of 1:1,000 and were the generous gift of Frank Solomon (Massachu- 
setts  Institute  of Technology, Cambridge,  MA).  Secondary  antibodies 
were used at a 1:1,000 dilution (Boehringer Mannheim Biochemicals, In- 
dianapolis, IN). Secondary antibodies for detection of Cdc31p and Dsk2p 
were FITC-conjugated goat anti-rabbit IgG. Anti-tubulin secondary anti- 
bodies were rhodamine-conjugated goat anti-rat IgG, and anti-90-kD sec- 
ondary antibodies were rhodamine-conjugated goat anti-mouse IgG. 4',6- 
diamidino-2-phenylindole (DAPI) was obtained from Accurate Chemicals 
and Scientific Corp. (Westbury, NY). 
EM  was  performed  as  described  in  Rose  and  Fink  (1987).  Strain 
MY3523 was grown to early logarithmic phase in SC-ura media containing 
2% raffinose. Galactose was added to 2% final concentration for 6 h, and 
cells were harvested for EM. Strain MY4240 was grown to early logarith- 
mic phase in YPD media, shifted to 37°C for 8 h, and harvested for micros- 
copy. 
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DSK2 Cloning and Mapping 
We cloned the DSK2-1 suppressor of the karlA17 mutant 
to elucidate its role in SPB duplication. Since the DSK2-1 
mutation is a dominant karlA17 suppressor with no other 
known  phenotype,  a  centromere-based library was  con- 
structed from the DSK2-1  karlAl7 strain (MS3145) to al- 
low cloning  by suppression  of the  karlzll7  temperature 
sensitivity.  The  library was  transformed  into  a  karlA17 
strain (MS2082) and grown at the permissive temperature 
of 23°C. To clone the DSK2-1 gene, the colonies were rep- 
lica printed to the nonpermissive temperature of 37°C and 
screened for temperature resistance. 
Seventeen  plasmids  were  identified  that  reproducibly 
conferred  temperature  resistance  upon  karlA17  (strain 
MS2082).  Restriction  analysis  determined  that  the  plas- 
mids  contained  different  overlapping  regions  of  DNA 
from the  same  part  of the  genome.  Plasmid  integration 
and a  linkage test confirmed that the cloned DNA corre- 
sponded to the authentic DSK2 locus. To map the DSK2 
gene,  a  DNA restriction  fragment common to  all of the 
plasmids  was  used  for  hybridization  to  lambda-prime 
clone grid filters provided by Linda Riles. This determined 
that  DSK2  physically maps to  the  right  arm of chromo- 
some XIII near the CDC65 gene. 
To  narrow  down  the  minimal  suppressing  region  of 
DNA,  the  smallest  plasmid  (~7.5  kb)  was  restriction 
mapped, and subclones were constructed (see Fig. 1 A) to 
test  for  suppression  of karlA17.  Only  the  entire  4.2-kb 
subclone  consistently  suppressed  karlA17  (Fig.  1  A)  so 
this entire subclone was sequenced.  Sequencing indicated 
that  this  subclone  contained  a  complete  open  reading 
frame (designated  ORF2  in  Fig.  1  B)  and  a  divergently 
transcribed  partial  open reading frame consisting of 776 
amino  acids  (designated  ORF1  in  Fig.  1  B).  Additional 
subclones mapped the suppressing activity to a 2-kb DNA 
fragment that contained the complete open reading frame 
(ORF2)  and  a  small portion of the  partial open reading 
frame.  To  determine  which  reading  frame  encodes  the 
DSK2 gene, the complete ORF2 was disrupted by insert- 
ing the URA3+ gene into the NcoI restriction site (see Fig. 
1 B). This plasmid could not suppress karlA17, indicating 
the DSK2 gene corresponds to the single complete open 
reading frame designated ORF2. In addition, this was fur- 
ther confirmed when the DSK2-1  mutation was found to 
map within this  open reading frame (see below). Partial 
suppression  of the  smaller subclones  was  likely to  arise 
from toxicity of the NHE-terminal part of ORF1  (Wolfe, 
D., and R. Keil, personal communication). 
DSK2 Encodes a  Ubiquitin-like Gene 
The  DNA  sequence  of the  RI/HIII fragment is  entered 
into  GenBank  under  accession  number  LA0587.  The 
DSK2 sequence is shown in Fig. 2 A  and encodes an open 
reading frame of 373  amino acids that is predicted to en- 
code a 41-kD protein. Homology searches indicated signif- 
icant homology between the first 76 amino acids of Dsk2p 
and ubiquitin.  Dsk2p is 36% identical and 55% similar to 
the yeast ubiquitin proteins (Ozkaynak et al., 1987; shown 
in Figs.  1 C  and 2 B).  Homology searches with the NH  2- 
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Figure 1.  DSK2 Subclones.  (A) pMR3165, the smallest kar1A17 
suppressing plasmid, was restriction mapped with a variety of en- 
zymes (R, EcoRI; K, Kpn; H, HIII; S, SpeI; X, XhoI; N, NcoI) 
that are designated  to scale. Smaller subclones were constructed 
as indicated  and tested for kar1A17  suppression  at 37°C. The 
symbol (+) indicates  suppression  of karlA17 to levels compara- 
ble to DSK2-1,  while the symbol (-) indicates  no suppression. 
Intermediate levels of suppression  and papillation  to wild type 
are indicated  by the following (+/-, +/--, and +/---). (B) A 4.2-kb 
R/H subclone,  pMR3153, suppressed kar1A17 to DSK2-1  levels 
and was sequenced  on both strands. This plasmid contained one 
partial open reading frame (ORF1) and a second complete open 
reading frame (ORF2).  ORF2 was disrupted  at the NcoI site with 
the URA3 gene to generate pMR2718 as indicated. This plasmid 
did not suppress  karlA17, indicating  that the DSK2 gene corre- 
sponds to ORF2. (C) Structure  of the Dsk2 protein. The NH2-ter- 
minal 76 amino acids of Dsk2p and Rad23p (boxes) are 55% and 
51%  similar  and  36%  and  22%  identical,  respectively,  to  the 
ubiquitin  protein (Ozkaynak et al.,  1987; Watkins  et al., 1993) 
and comprise ubiquitin-like  domains. The ubiquitin-like  proteins 
have unique COOH-terminal tail regions (line). 
terminal 76  amino acids of Dsk2p identified  many ubiq- 
uitin  homologues  that  have  significant  homology  to 
Dsk2p. For example, Dsk2p is 52% similar and 31% iden- 
tical to the first 76 amino acids of the yeast Rad23 protein 
(Watkins et al., 1993; see Figs. 1 C and 2 B) and 61% simi- 
lar and 36% identical to the human XP-C proteins (Masu- 
tani et al., 1994;rdata not shown).  Since all ubiquitin pro- 
teins are >90%  identical and Dsk2p is 36%  identical, we 
classify Dsk2p as  a  ubiquitin-like  protein  (see Fig.  1  C). 
Homology searches with the  COOH-terminal domain of 
Dsk2p did  not  identify any proteins with  significant  ho- 
mology, including  the  yeast  Rad23  protein.  Because  we 
cloned  the  DSK2-1  mutant  allele  first,  the  wild-type 
DSK2+  gene and the DSK2-2 suppressor were recovered 
by the gap-repair technique (Orr-Weaver et al., 1983)  and 
sequenced.  There  is  a  single  base  pair  change  between 
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R3153 (see Fig. 1) was sequenced and the 3' 1,853 nucleotides 
(corresponding to ORF2 in Fig. 1 B) that include  the DSK2+ 
gene are shown. The DSK2 open reading frame is designated  to 
begin with nucleotide  1, and upstream nucleotides  -230 to 1 are 
shown, as well as 518 downstream nucleotides.  The dsk2 deletion 
encompasses nucleotides  +1  to  +1130  to  eliminate  the  entire 
DSK2 gene. The nucleotide  numbers are indicated  at the left of 
the sequence. The DSK2 gene encodes a 373-amino acid protein. 
The protein  sequence  is indicated  under  each codon with  the 
amino acid numbers indicated on the right of the sequence. In the 
DSK2-1 and DSK2-2 mutants, codon 69 (underlined) is changed 
from CAT to TAT, which changes amino acid 69 from histidine 
to tyrosine.  These sequence  data are available  from GenBank/ 
EMBL/DDBJ under accession number L40587. (B) Dsk2p pile- 
up. The first 76 amino acids of Dsk2p and Rad23p (Watkins et al., 
1993), the ubiquitin-like  domains, are aligned with the yeast ubiq- 
uitin protein (Ozkaynak et al., 1987). Identical residues  are indi- 
cated by black  boxes. The Dsk2p ubiquitin-like  domain is 55% 
similar and 36% identical  to ubiquitin  and 52% similar and 31% 
identical  to Rad23p.  There is no significant  homology between 
the COOH-terminal regions of Dsk2p and Rad23p. Amino acids 
numbers are indicated  above the sequence. 
DSK2-1 and DSK2+, which mutates amino acid 69 in the 
ubiquitin-like  domain  from  a  histidine  in  wild-type 
DSK2+ to a tyrosine in DSK2-1 (the codon is underlined 
in Fig. 2 A).  Sequencing  of the DSK2-2 suppressor indi- 
cated  it contains  the  same mutation as the DSK2-1  sup- 
pressor, although  the  two  alleles  were  isolated  indepen- 
dently (Vallen et al., 1994).  It seems likely that the DSK2 
suppressor is a very special form of the protein. 
The Dsk2p Ubiquitin-like Domain Is Not Cleaved 
The homology between Dsk2p and ubiquitin led us to test 
for  similarities  between  the  proteins.  Full-length  Dsk2p 
and  Dsk2-1p were  cloned into  bacterial  GST expression 
vectors to  allow expression  and  purification  of recombi- 
nant Dsk2 protein. When expressed in bacteria, the Dsk2 
protein migrates at a molecular weight of ~41,000, consis- 
tent with the predicted molecular weight (data not shown). 
A  Western  blot  was  performed with  anti-ubiquitin  anti- 
bodies on the purified bacterial GST-Dsk2 fusion proteins 
from bacteria and determined that anti-ubiquitin antibod- 
ies  weakly cross-reacted  with  the  Dsk2  protein  but  not 
with GST protein (data not shown). 
Since  all  ubiquitin  proteins  are  synthesized  as  fusion 
proteins that are subsequently cleaved by cellular hydro- 
lases  to  generate  free  ubiquitin,  we  tested  whether  the 
ubiquitin-like  domain  is  cleaved from the  Dsk2  protein. 
Ubiquitin has a glycine residue at amino acid 76 that is im- 
portant for hydrolase recognition, and Dsk2p has a proline 
residue at this position, suggesting that Dsk2p would not 
be cleaved by the ubiquitin hydrolases. Nevertheless, a dif- 
ferent set of hydrolases might exist to cleave Dsk2p. Poly- 
clonal antibodies were generated against purified Dsk2 re- 
combinant  protein  and  subsequently  purified  on  a 
bacterial Dsk2p affinity column. A  Western blot on a total 
yeast  protein  extract  using  anti-Dsk2p  antibodies  deter- 
mined that the Dsk2p antibodies recognize a  single band 
in yeast corresponding to 41  kD  (Fig.  3 A, lane 1).  This 
band  is the same molecular weight as the  bacterially ex- 
pressed Dsk2p and is not present in a dsk2A yeast strain 
(Fig. 3 A, lane 2). Since the Dsk2p antibodies recognize a 
single protein of the predicted full-length Dsk2 protein in 
yeast,  the  ubiquitin-like  domain  did  not  appear  to  be 
cleaved. 
To rigorously determine whether the  ubiqutin-like  do- 
main  is  cleaved,  we  purified  antibodies  specific  to  the 
NH2-terminal ubiquitin-like  (ub-like) domain. A  GST fu- 
sion  containing  the  Dsk2  ub-like  domain  was  expressed 
and purified from bacteria and coupled to a column to pu- 
rify antibodies specific to the Dsk2p ub-like domain. The 
NH2-terminal antibodies  and anti-Dsk2p full-length  anti- 
bodies were used for Western blotting of total yeast ex- 
tracts; the ub-like domain antibodies recognized the same 
band as the full-length antibodies (Fig. 3 B, lane 1), indi- 
cating that the ub-like domain is present on the full-length 
protein. To confirm that the NH2-terminal antibodies are 
specific to the ub-like domain, a  competition experiment 
with  pure  recombinant  Dsk2p  GST-ub-like protein  was 
performed. Western blotting of total yeast extracts with ei- 
ther  Dsk2p  NH2-terminal  antibodies  or  full-length  anti- 
bodies  was  performed  in  the  presence  of  increasing 
amounts of ub-like protein. The Dsk2p GST-ub-like pro- 
tein  fully competed away the  Western  blot signal of the 
anti-ub-like antibodies (Fig. 3 C), indicating that these an- 
tibodies are specific to the ub-like domain of Dsk2p. How- 
ever,  the  ub-like  protein  could  only  partially  compete 
away the signal of the full-length antibodies (Fig. 3 C), in- 
dicating  that  the  full-length  antibodies  recognize  the 
COOH-terminal domain of Dsk2p. 
Dsk2p and Cdc31p Stabilities Are Not Altered by the 
DSK2-1 Mutation 
One of the cellular functions of ubiquitin is to polyubiqui- 
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B) Extracts from wild-type strains (MS1554, lane 1) and dsk2A 
strains (MS3574, lane 2) were prepared, separated on denaturing 
polyacrylamide gels, and transferred to membrane. (A) Affinity- 
purified full-length anti-Dsk2p antibodies used for Western blot- 
ting recognized a single band of 41 kD in wild-type extracts and 
no  protein  in  dsk2A  extracts.  (B)  Purified  NH2-terminal  anti- 
Dsk2p antibodies used for Western blotting recognized the same 
band of 41 kD as the full-length antibodies.  (C) A  competition 
experiment was performed to show that the NH2-terminal Dsk2p 
antibodies  are  specific  to the  NH  2 terminus  and recognize the 
same size protein as the full-length antibodies. 0, 0.5, 5, or 50 mg 
of  purified  NH2-terminal  Dsk2  protein  (indicated  above  the 
blots) was incubated with either NH2-terminal Dsk2p antibodies 
or  full-length  antibodies  during  Western  blotting  of wild-type 
yeast strains.  The Western blot shows that 0.5 mg of pure NH2- 
terminus is sufficient  to compete away the binding of the NH  2- 
terminal Dsk2p antibodies,  but 50 mg of NH2-terminal protein 
cannot fully compete away the binding of the full-length Dsk2p 
antibodies.  Therefore, the NH2-terminal antibodies  are specific 
to the NH2 terminus and recognize the same protein as the full- 
length  antibodies,  showing  that  the  ubiquitin-like  domain  of 
Dsk2p is not cleaved. 
tinate  substrates  on one or more lysine residues  to cause 
substrate  degradation via the proteasome  (for review see 
Ciechanover,  1994).  Although the  details  of this  process 
are not completely understood,  site-directed  mutagenesis 
on ubiquitin was performed to define residues that are im- 
portant for the resulting degradation of substrates  (Ecker 
et  al.,  1987).  In this  study, it was determined  that one of 
the ubiquitin residues important in the subsequent degra- 
dation of substrates is histidine-68.  When this residue was 
mutated  to  a  lysine,  the  BSA  substrate  that  was  conju- 
gated to the mutant ubiquitin  was only degraded at 30% 
the rate of wild-type ubiquitin-conjugated BSA. Although 
the mechanism of the change in stability is unknown, the 
mutation  in  ubiquitin  somehow decreases  substrate  pro- 
teolysis.  Since  both  the  DSK2-1  and  DSK2-2  mutations 
change  histidine-69  (which  corresponds  to  the  ubiquitin 
histidine  68) to a  tyrosine, it was possible that they affect 
the stability  of a  ubiquitinated  protein  by inhibiting pro- 
teolysis. 
We therefore tested the stability of Dsk2p and Cdc31p 
in  DSK2+  and  DSK2-1  strains  since  mutations  in  both 
genes suppress the karl A17 temperature sensitivity. Pulse- 
chase experiments were performed on wild-type (MS1554) 
and DSK2-1 (MS374) strains by adding 35S-translabel for 5 
min  and  harvesting  cells  at  different  times  during  the 
chase.  The  cells  were  lysed,  and  immunoprecipitations 
with  anti-Dsk2p  and  anti-Cdc31p  were  performed,  sepa- 
rated  on denaturing  gels,  and subjected  to autoradiogra- 
phy to determine  the amount of labeled protein. This de- 
termined that both Cdc31p (Fig. 4 A) and Dsk2p (Fig. 4 B) 
have very long half-lives (>8 h) in wild-type and DSK2-1 
strains,  so a  change in their  stability is unlikely to be the 
Figure 4.  The stabilities  of Dsk2p and Cdc31p are not altered in 
DSK2-1  strains.  (A and B) A  pulse-chase experiment was per- 
formed on DSK2+ and DSK2-1  strains to determine the stability 
of Cdc31p and Dsk2p. Equivalent volumes of labeled cells were 
harvested at 0, 2, 4, and 8 h (indicated above the blots), and pro- 
teins  were  immunoprecipitated  with  anti-Cdc31p  (A)  or  anti- 
Dsk2p (B) antibodies. The proteins were resolved on denaturing 
polyacrylamide gels and subjected to autoradiography that indi- 
cated no differences in stability  between the strains.  (C) A PGAL- 
DSK2 shut-off experiment. The DSK2 + and DSK2-1 genes were 
placed under the control of the galactose-inducible GALl pro- 
moter and expressed in dsk2A  strains as the sole source of Dsk2 
protein. Protein synthesis  was repressed by the addition of glu- 
cose to the  media,  and  equivalent numbers  of cells  were  har- 
vested at 0, 3, 7, 9, and 23 h (indicated above the blots) after the 
addition of glucose.  Extracts from the cells were prepared, sepa- 
rated on a  denaturing polyacrylamide gel,  and transferred  to a 
membrane. Western blots of the membrane with anti-Dsk2p anti- 
bodies are shown and indicate that the stability  of the Dsk2p and 
Dsk2-1 proteins is equivalent. 
•  mechanism  of DSK2-1  suppression  of karlA17.  We  also 
tested  the  stability  of Cdc31p  and  Dsk2p  in  a  karlzll7 
strain  at  the permissive  and nonpermissive  temperatures 
by pulse-chase to determine whether their stability was al- 
tered during suppression.  Again, the half-lives of Cdc31p 
and Dsk2p were very long and therefore unlikely to be rel- 
evant  to  the  suppression  (data  not  shown).  In addition, 
pulse-chase  experiments  with  very  short  and  long  time 
points were conducted, and we did not detect the presence 
of any alternative forms of Dsk2p, supporting our observa- 
tion that the NH2-terminal domain of Dsk2p is not cleaved 
(see above). 
To determine by an alternative  method whether Dsk2p 
and Dsk2-1p have equal half-lives, a galactose shut-off ex- 
periment was performed. The DSK2+ and DSK2-1 genes 
were placed  under  the control of the  galactose inducible 
GALl  promoter  (Yocum et  al.,  1984).  They were  trans- 
formed  into  a  dsk2A  strain  (MS3574,  see  below)  and 
grown  in  galactose  for  2  h  to  induce  expression  of the 
Dsk2 proteins.  Glucose was added to repress further syn- 
thesis of the proteins, and aliquots of cells were harvested 
at various time points. When equal numbers of cells were 
subjected to a Western blot with anti-Dsk2p antibodies to 
monitor the protein levels, the turnover rate of Dsk2p and 
Dsk2-1p appeared to be equivalent (Fig. 4 C). 
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for Function 
Since the DSK2-1 mutation maps to the ubiquitin-like do- 
main, we tested whether the ub-like domain is sufficient 
for the suppression of karlA17. The wild-type and DSK2-1 
ub-like  domains  were  cloned  into  a  centromere-based 
yeast vector under the control of the regulated galactose 
promoter.  They  were  then  transformed  into  wild-type 
(MS1554)  and  karlA17 (MS2082)  strains.  To check that 
the ub-like proteins are expressed and stable, the strains 
were grown in the presence of galactose, and yeast extracts 
from these strains were prepared and separated on dena- 
turing gels. The proteins were transferred to membranes 
and probed with anti-Dsk2p antibodies to detect the pro- 
tein. The proteins were expressed to the same level as the 
full-length  Dsk2p  (data  not  shown).  These  strains  were 
then grown at 37°C to test for suppression of karlA17. The 
ub-like domain of DSK2+  and DSK2-1 did not suppress 
karlzal 7, indicating that the tail of the protein is important 
for  the  suppression  (data  not  shown).  In  addition,  the 
overexpression of the truncated proteins was not toxic, un- 
like overexpression of the full-length protein (see below). 
DSK2 and RAD23 Are Involved in SPB Duplication 
To  learn  more  about the  function  of the DSK2  gene,  a 
two-step  gene  replacement  method  (Orr-Weaver  et  al., 
1983) was used to delete the entire DSK2 gene. The dele- 
tion  did  not  affect growth  rate  at  temperatures  ranging 
from 23  ° to 37°C. Since the dsk2A had no detectable phe- 
notype, it seemed possible this might be due to functional 
redundancy  with  another  gene(s)  such  as  the  ubiquitin- 
like gene, RAD23. Although a rad23A strain is UV sensi- 
tive (Watkins et al., 1993), it displays no growth defects at 
temperatures ranging from 23  ° to 37°C.  To test for func- 
tional  redundancy  between  the  ubiquitin-like  genes,  we 
generated a rad23A dsk2A double mutant. The growth rate 
of the double mutant was normal at 23  ° and 33°C (Table 
II), but growth was severely inhibited at 35  ° and 37°C (Ta- 
ble  II).  Growth  curves  were  performed  on  wild-type, 
dsk2A,  rad23A,  and  dsk2A  rad23A  strains  at  37°C.  The 
dsk2A, rad23A,  and  wild-type strains  had  similar growth 
rates (Fig. 5 A). Growth of the dsk2A rad23A double mu- 
tant arrested within i  h after the shift to the nonpermissive 
temperature (Fig. 5 A). 
To determine whether the temperature-sensitive defect 
in  the dsk2A rad23A  double mutant was due  to a  defect 
in SPB  function,  indirect  immunofluorescence  was  per- 
formed  to  visualize  the  microtubules,  the  SPBs,  and 
Cdc31p localization. Wild-type, dsk2A, rad23A, and dsk2za 
rad23A  strains were grown to early logarithmic phase  at 
30°C, shifted to 37°C for 6 h, and formaldehyde fixed for 
indirect  immunofluorescence.  The  wild-type  and  single 
mutant  strains  had  normal  distributions  of cells in  each 
phase  of the  cell  cycle  (Fig.  5  C).  In  the  rad23A  dsk2A 
strain, there was an increase in large-budded cells to 47% 
(compared to 11% in the isogenic wild-type strain; Fig. 5 
C).  DAPI staining  to visualize the  nucleus  in these  cells 
showed that the nucleus was abnormally positioned in the 
neck of the large-budded cells, resulting in a "cut" pheno- 
type  (Fig.  6  K).  In contrast,  the  wild-type, rad23A,  and 
dsk2A strains had either an elongated nucleus or two nu- 
clei in large-budded cells (Fig. 6, B, E, and H). The rad23A 
strain had a  small percentage (5%) of large-budded cells 
with a single nucleus positioned in the neck (Fig. 5 C). Im- 
munofluorescent staining of tubulin to visualize the micro- 
tubules determined that the wild-type, dsk2A, and rad23A 
strains had wild-type cytoplasmic and nuclear microtubule 
morphology (Fig. 6, C, F, and/). In large-budded cells, the 
microtubules in  these  strains  extended  between  the  two 
nuclei, indicating the presence of an elongated bipolar mi- 
totic spindle (Fig. 6, C, F, and/). The small percentage of 
large-budded cells with the  cut phenotype in the rad23A 
strain contained a short bipolar spindle that extended be- 
tween  the  two  edges  of  the  nucleus  as  defined  by  the 
DAPI staining  (data  not  shown).  In contrast,  the  large- 
budded cells in the dsk2A rad23A strain had a single vertex 
of microtubules on the edge of the nucleus, indicating the 
presence of a  monopolar spindle  (Fig.  6,  L). This defect 
suggested that the large-budded cells in the dsk2A rad23A 
strain had either a single SPB or duplicated SPBs that had 
not separated. 
To visualize the SPBs, indirect immunofluorescence was 
performed using anti-90-kD antibodies generated against 
partially purified SPBs by Rout  and  Kilmartin (1990)  or 
anti-Cdc31p antibodies (Biggins and Rose, 1994).  Staining 
with  SPB  antibodies  on  wild-type,  dsk2A,  and  rad23A 
strains was normal: the distribution  of cells with one and 
two SPBs matched expectations based on the distribution 
of cells in the cell cycle (Fig. 5 C). Unbudded  cells and a 
few small-budded cells should have a  single SPB, and all 
other cells should have two SPBs. In wild-type, dsk2A, and 
rad23A strains, ~60% of the cells had a single SPB as visu- 
alized as a dot of 90-kD staining (Fig. 7, B, D, and F) on 
the edge of the nucleus as defined by DAPI staining (Fig. 
7, A,  C, and E). This percentage correlates well with the 
~60% unbudded cells (Fig. 5 C). In contrast, there was an 
increase in the percentage of cells containing a single SPB 
from 60% to 87% in the dsk2A rad23A strain at 37°C (Figs. 
5 C  and 7 H). We attribute the increase to 87% of single 
SPBs to the increase in large-budded cells with a monopo- 
Table II. Genetic Interactions between CDC31, KARl, DSK2, 
and RAD23 
Strain  Plasmid  23°C  33°C  35°C  37°C 
karlA17  vector  +  +  -  - 
2tx-CDC31 +  +  +  +  +/- 
CDC31-16  +  ~  +  +  -/+ 
DSK2-1  +  +  +  -/+ 
dsk2A rad23A  vector  +  +  -  - 
2wCDC31  ÷  +  +  +  - 
CDC31-16  +  +  +  - 
DSK2-1  +  +  +  + 
kar1A17dsk2A  rad23A  vector  +  -  -  - 
21x-CDC31 ÷  +  +  -/+  - 
CDC31-16  +  +  +  - 
DSK2-1  +  +  +  -I+ 
Wild  type  vector  +  +  +  + 
2p,-CDC31 +  +  +  +  + 
CDC31-16  +  +  +  + 
DSK2-1  +  +  +  + 
Strains were transformed with plasmids as indicated, and growth was tested at the var- 
ious temperatures. 
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Figure 5.  dsk2A rad23A strains and DSK2 overexpression strains 
have defects in SPB  duplication. (A)  A  growth curve was per- 
formed  on  wild-type  (open  squares),  dsk2A  (closed  circles), 
rad23 A (open circles), and ds  k2 A rad23 A (closed squares) strains 
at 37°C.  Cells were plated every hour, and the number of viable 
cells were calculated. The dsk2,:l rad23A  strain arrests after 1 h, 
while the other strains have equivalent growth rates at 37°C.  (B) 
A  growth  curve was  performed  on PCAL-DSK2+  (circles)  and 
PGAcDSK2-1 (squares) strains that were grown in glucose (open) 
or galactose  (closed)  for  10 h  at 30°C.  Cells were plated every 
hour, and the number of viable cells was calculated. The overex- 
pression of both genes causes decreased viability. (C) The distri- 
bution of cells in wild-type, dsk2A, rad23A,  and dsk2A rad23A 
strains after  6 h  at 37°C were  calculated by counting cells that 
were formaldehyde fixed.  Greater than 200 cells were  counted 
for each strain, and the percentage of each type of cell is indi- 
cated  below  the  pictorial  representations.  The  pictures  above 
each  column represent  the  following, respectively:  unbudded 
cells, small-budded cells, large-budded cells with nuclei that have 
separated or are in the process of separating, large-budded cells 
with a single nucleus in the neck and a short spindle, and large- 
budded cells with a monopolar spindle. In addition, the percent- 
Figure  6.  Indirect  immunofluorescence  on  wild-type,  dsk2A, 
rad23A, and dsk2A rad23A strains. Wild-type (A-C), rad23A (D- 
F), dsk2A (G-0, and dsk2A rad23A  (J-L) strains were grown at 
37°C for 6 h and fixed for indirect immunofluorescence. Nomar- 
ski optics are shown in A, D, G, and J, DAPI staining in B, E, H, 
and K, and anti-tubulin staining in C, F, I, and L. Large-budded 
cells in all strains except the dsk2A rad23A strain have wild-type 
tubulin staining indicated by an elongated mitotic spindle (C, F, 
and/) with separated DNA (indicated by DAPI staining in B, E, 
and H). In the dsk2A rad23A  strain, the nucleus is stuck in the 
neck (indicated by DAPI staining in K), and there is a monopolar 
spindle indicated by the tubulin staining (L). 
age of cells containing one or two SPBs was calculated by count- 
ing >200 cells that were stained with anti-SPB antibodies (90-kD 
or Cdc31p). The experiment was performed twice, and the aver- 
ages of both experiments are reported. The same experiment was 
performed on cells containing the DSK2+ and DSK2-1 genes un- 
der  control  of  the  GALl  promoter.  The  genes  were  overex- 
pressed  by growth  in galactose  for  10 h  and processed  as  de- 
scribed above. 
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expression strains. To determine the frequency of cells containing 
one or two SPBs, anti-Cdc31p  and anti-90-kD  indirect  immuno- 
fluorescent  staining  was  performed  on  wild-type  (A  and  B), 
rad23  A ( C and D ), dsk2 A (  E and F), and dsk2 A rad23  A strains (G 
and/4) grown at 37°C for 6 h. The frequencies  of cells containing 
one or two SPBs are reported in Fig. 5 C. Anti-90-kD  staining 
shown in B, D, F, and H indicates  the SPB on the nucleus that is 
defined  by DAPI staining  in A,  C,  E,  and  G.  The wild-type, 
dsk2A, and rad23A strains contain numerous cells containing two 
SPBs (B, D, and F). The dsk2A rad23A strain consists mainly of 
cells with a single dot of 90-kD staining  and therefore contains 
many large-budded cells with a single SPB (H). The same experi- 
ment was performed on PCAL-DSK2 strains  that were grown in 
galactose for 10 h. A strain containing the vector is shown in I and 
J, and a  strain  containing  PaAL-DSK2-1 is shown  in K  and L. 
Anti-90-kD  staining  and anti-Cdc31p  staining were the same in 
all  strains,  and  anti-90-kD  staining  is shown  in J,  anti-Cdc31p 
staining in L, and DAPI in I and K. The overexpression of DSK2-1 
also causes the accumulation  of large-budded cells containing  a 
single SPB in which Cdc31p is still localized to the SPB (L). 
lar spindle  observed by tubulin  staining.  Few cells were 
ever seen in the dsk2A rad23A strain with adjacent SPBs, 
suggesting the monopolar tubulin  staining is due  to cells 
with unduplicated SPBs. 
To  determine  whether  the  monopolar  spindles  in  the 
dsk2A  rad23A  strain contain  a  single  SPB  or  duplicated 
but unseparated SPBs, EM was performed. Serial sections 
of 11  large-budded  cells with a  single nucleus  were  ana- 
lyzed.  Each  cell was followed through six to  twelve sec- 
tions. Seven of these cells (66%)  contained  a  single SPB 
(Fig. 8, A  and B). Absence of a second SPB in the preced- 
ing and subsequent sections confirmed that the  SPB had 
not  duplicated.  The  unduplicated  SPBs  were  often  en- 
larged  and  embedded within  a  deep invagination  of the 
nucleus  (Fig.  8,  A  and  B),  resembling the  phenotype of 
karl  (Rose and Fink,  1987)  and cdc31  (Byers, 1981)  mu- 
tants. The four remaining cells contained duplicated SPBs, 
either in a bipolar configuration (three of the four cells) or 
in a side by side configuration (one of the four cells) (data 
not shown). These results are in close agreement with the 
immunofluorescence  data  in  which  ~60%  of the  large- 
budded  cells contained  a  monopolar spindle  (Fig.  5  C). 
Therefore, the  monopolar cell  cycle block of the  dsk2A 
rad23A strain was due to a block in SPB duplication. 
Since  the  temperature-sensitive  defect  of karlA17 re- 
sults in a SPB duplication defect due to mislocalization of 
Cdc31p, we tested whether Cdc31p was properly localized 
to the SPB in the rad23A dsk2A strain at 37°C.  In all four 
strains, Cdc31p staining always colocalized with the 90-kD 
staining, indicating that Cdc31p localization is not altered 
in the double mutant (data not shown). 
We next tested whether the CDC31 mutant suppressors 
of karlA17 suppressed the temperature sensitivity of the 
dsk2A rad23A strain. This would indicate  that the  defect 
involved CDC31 function. We found that both CDC31-16 
and  high  copy  CDC31+  suppressed  the  rad23A  dsk2A 
temperature-sensitive strain at 35°C but not at 37°C (Table 
II). In addition, we isolated CDC31+ multiple times in a 
screen for high copy suppressors of the temperature-sensi- 
tive  defect  of the  rad23A  dsk2A  double  deletion  strain 
(Ivanovska, I., and M. Rose, unpublished results). There- 
fore, the dsk2A rad23A defect is at least partly mediated 
through Cdc31p. 
Since RAD23 is functionally redundant with DSK2 for 
SPB  duplication,  we  tested whether DSK2 has  a  role in 
DNA repair like RAD23.  To do  this, wild-type, rad23A, 
dsk2A,  and  rad23A  dsk2A  strains  were  plated  and  sub- 
jected to increasing UV light.  We found that the rad23A 
and rad23A dsk2A strains were both equally UV sensitive, 
and  the  dsk2A  strain  was  not  UV  sensitive  (data  not 
shown). 
DSK2 0verexpression Blocks SPB Duplication 
The overexpression of the Karlp SPB component is toxic 
and causes a large-budded arrest with a monopolar spindle 
(Rose  and  Fink,  1987).  Indirect immunofluorescence on 
overexpressed Karlp indicates it forms a  large aggregate 
that  is  no  longer  localized  to  the  SPB  (Rose  and  Fink, 
1987).  Cdc31p  is  associated with  this  aggregate  (Biggins 
and Rose, 1994), suggesting that the block in SPB duplica- 
tion by overexpression of KARl may be due to a titration 
of SPB components away from the SPB. To determine if 
DSK2  overexpression  has  phenotypes  similar  to  KARl 
overexpression,  we  constructed  plasmids  in  which  both 
DSK2+ and DSK2-1 were placed under the control of the 
GALl promoter (Yocum et al., 1984).  When high levels of 
Dsk2p were induced by growth on galactose plates, growth 
was  inhibited.  To  carefully assess  the  growth  defects  of 
overexpression  of  DSK2+  and  DSK2-1,  growth  curves 
were performed in the presence and absence of galactose. 
Cells from both  strains  were  grown  to  early logarithmic 
phase in the presence of raffinose. Glucose was added to 
half of the culture, galactose was added to the other half, 
and cells were plated for viability on glucose plates every 
hour for 10 h. The cessation of growth indicated that over- 
expression of both DSK2+ and DSK2-1 was toxic (Fig. 5 B). 
To  determine  if the  toxicity  of DSK2  overexp~ssion 
was due to a defect in SPB duplication, cells were grown in 
galactose or glucose for 10 h and processed for indirect im- 
munofluorescence  as  described  above.  In  the  overex- 
pressed DSK2 strains (Fig. 5 C), there was an increase in 
the  percentage of large-budded  cells.  Wild-type cultures 
had 11% large-budded cells while PGAL-DSK2+ had 25% 
and PCAL-DSK2-1 had 43% large-budded cells (Fig. 5 C). 
DAPI  staining  of the  overexpressed DSK2  strains  indi- 
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strain and DSK2-1 overexpression 
strain.  A  dsk2/l rad23A  strain (A 
and B) was grown at 37°C for 8 h 
and a PCAL-DSK2-1 strain (C and 
D) was grown in galactose for 6 h. 
Cells from both cultures were pre- 
pared for EM. Large-budded cells 
were chosen for analysis,  and se- 
rial  sections surrounding the SPB 
were  examined.  In  7  out  of  11 
large-budded dsk2A  rad23A  cells, 
a  single  SPB was observed span- 
ning  two  to  four  serial  sections. 
No additonal SPBs were observed 
in either  neighboring sections or 
at the opposite end of the nuclear 
microtubule  bundle.  Two  exam- 
ples  are  shown  in  A  and  B.  In 
three cells, duplicated SPBs were 
observed on the opposite side of 
the  nucleus,  at  the  other  end  of 
the  nuclear  microtubule  bundle, 
indicating  that  a  bipolar  spindle 
had formed. In one cell,  a dupli- 
cated SPB was found adjacent to 
the first SPB.  These results  indi- 
cated  that  the  monopolar  large- 
budded dsk2A  rad23A cells  were 
blocked  in  SPB  duplication  and 
not in SPB separation. The SPBs 
in serial  sections of 12 large-bud- 
ded  cells  overexpressing DSK2-1 
were also scored by the above cri- 
teria. Nine large-budded cells con- 
tained a single SPB (two examples 
are shown in C and D), and three 
contained a bipolar spindle. These 
results  indicate  that  overexpres- 
sion  of  Dsk2-1p  also  caused  a 
block in SPB duplication and not 
in SPB separation. 
cated that nuclei in the large-budded  cells had an abnor- 
mal nuclear position in the neck of the cell (Fig. 9, E  and 
H).  Immunofluorescent staining  of tubulin  of these  cells 
indicated  that  overexpression  of  DSK2+  blocked  cells 
with a short bipolar spindle (Fig. 9, E  and F). Immunofluo- 
rescent  staining  of the  anti-90  kD protein  indicated  that 
the percentage of cells with one SPB was lower than wild- 
type, and there was an increase in cells with two SPBs (Fig. 
5 C). Therefore, the overexpression of DSK2+ causes the 
accumulation of cells with short spindles. In contrast, anti- 
tubulin  staining  of the  overexpressed  DSK2-1  large-bud- 
ded cells indicated that they contained a monopolar spin- 
dle  (Fig.  9  /)  as  defined  by  the  single  vertex  of tubulin 
staining on the edge of the nucleus (Fig. 9 H). When im- 
munofluorescent  staining  of the  anti-90-kD  protein  was 
performed on these cells, we found an increased percent- 
age of cells with a single SPB compared to wild-type cells 
(Fig. 5 C). 
To confirm that the single SPB observed by immunoflu- 
orescence  was  due  to  a  block in  SPB  duplication,  serial 
section EM was performed on cells overexpressing DSK2-1. 
Serial sections of twelve large-budded cells that contained 
a  single nucleus were followed through six to fifteen sec- 
tions. Nine of the cells (75%) contained a single SPB (Fig. 
8,  C  and  D).  The  three  other  cells  contained  duplicated 
SPBs that were separated to opposite poles of the nucleus. 
The percentage of cells with a  single SPB determined  by 
EM  (75%)  correlated  well  with  the  percentage  of cells 
containing a  monopolar spindle  determined  by immuno- 
fluorescence (69%). Therefore, overexpression of DSK2-1 
also caused a block in SPB duplication. 
To determine whether the SPB duplication defect could 
be  due  to  Cdc31p  mislocalization,  immunofluorescent 
staining of anti-Cdc31p was performed on these strains. In 
all cases, anti-Cdc31p staining corresponded to the 90-kD 
staining (data not shown, but e.g., see Fig. 7 L), indicating 
that Cdc31p localization at the sole SPB was not affected. 
DSK2, CDC31, and KARl  Interactions 
We previously determined that Karlp and Cdc31p physi- 
cally interact, and that the function of Karlp in SPB dupli- 
cation is to localize Cdc31p to the SPB (Biggins and Rose, 
1994). To determine the relationship of the DSK2 gene to 
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strains. Cells containing the PGAL vector  (A-C), PGAL-DSK2+ 
(D-F), and PGAL-DSK2-1 (G-I) were grown in galactose for 10 h 
and formaldehyde fixed for indirect immunofluorescence. Exam- 
ples of large-budded  cells indicated by Nomarski optics (A, D, 
and G) show that the nucleus in DSK2 overexpressed strains (in- 
dicated by DAPI in B, E, and H) is abnormally positioned in the 
neck of the cell. In contrast to wild-type cells, which contain an 
elongated  mitotic  spindle as  indicated  by anti-tubulin  staining 
(C), the PGAL-DSK2+ cells contain a short bipolar spindle (F), 
while PGAL-DSK2-1 cells contain a monopolar spindle (I). 
the KARl  and  CDC31  genes, we tested  genetic interac- 
tions between these genes. First, we tested for genetic in- 
teractions between dsk2A and karlA17 since DSK2 is not 
an essential gene. A  dsk2A karlA17 strain was generated 
and grew normally at 23  ° and 30°C. When the strain was 
tested for growth at 37°C, it was still temperature sensitive 
due to the karlA17 allele,  indicating that there is no ge- 
netic interaction between the dsk2A  and kar1A17 at any 
temperature  (data  not shown).  Since  we  found that  the 
DSK2  and RAD23  genes are functionally redundant, we 
tested whether the RAD23 gene interacted with karlA17. 
A  rad23A  kar1A17  strain  was  generated,  and  like  the 
karlA17 dsk2A strain, the rad23za  did not display any ge- 
netic interactions with karlA17 (data not shown). We pre- 
dicted that a kar1A17 dsk2A rad23A strain would exhibit a 
synthetic effect if the KARl, DSK2, and RAD23 genes ge- 
netically interact to initiate SPB duplication. We therefore 
generated a  kar1A17 rad23A dsk2A strain and found it is 
temperature  sensitive  at 37°C (Table  II), indicating that 
the  dsk2A  rad23A  double  deletion  and  karlzal7  do  not 
suppress each other.  Strikingly, however, the triple dele- 
tion strain is now temperature sensitive for growth at 33°C 
(Table II), a temperature permissive for the kar1A17 (Ta- 
ble II) and the dsk2A rad23za strains (Table II). This syn- 
thetic phenotype suggests  that Dsk2p/Rad23p affect cell 
function in a manner related to Karlp function. 
We  previously proposed  that  the  CDC31  alleles  may 
suppress  karl  mutants  via  an  increased  interaction  with 
another SPB component since  CDC31  suppressor muta- 
tions restore the localization of Cdc31p to the  SPB in  a 
karl deletion strain (Vallen et al., 1994; Biggins and Rose, 
1994).  We therefore tested whether the DSK2 mutations 
also restore Cdc31p localization to the SPB in a karl dele- 
tion strain.  Indirect immunofluorescence was performed 
on a karlzl2 DSK2-1  strain (MS2645) to localize Cdc31p. 
As shown in Fig. 10, Cdc31p staining (B) corresponds to 
the 90-kD staining (C) in the karlA DSK2-1 strain, show- 
ing that DSK2-1  relocalizes Cdc31p to the SPB in the ab- 
sence of karl. If Dsk2p is the component that CDC31 sup- 
pressors  interact  with  to  bypass  KARl  function,  then 
DSK2  should  be  required  for  CDC31-16  to  suppress 
kar1A17.  However,  we  constructed  a  CDC31-16  dsk2A 
karlA17  strain  and  found  that  CDC31-16  suppressed 
karlA17  in  either  the  presence  or  absence  of DSK2+ 
(data not shown). This indicates that Cdc31-16p suppres- 
sion of karlA17 occurs either by interacting with factors in 
addition to Dsk2p or independent of Dsk2p. One potential 
candidate for this factor is the RAD23 gene that is func- 
tionally  redundant  with  DSK2.  We  therefore  tested 
whether the CDC31 suppressors can suppress the temper- 
ature  sensitivity in  a  kar1A17  dsk2A  rad23za  strain.  The 
CDC31-16 allele (Table I1) and high copy CDC31+  (Ta- 
ble II) both suppress the triple deletion strain at 33°C and 
35°C. As was found for the dsk2A rad23A  strain,  CDC31 
suppressors did not suppress  the dsk2A  rad23A  kar1A17 
strain at 37°C (Table II). These data show that RAD23 and 
DSK2  are  not  required  for  CDC31  suppression  of 
karlza17, nor is KARl  required for suppression of rad23A 
dsk2A. Taken together, these results indicate that KARl, 
RAD23,  and  DSK2  functions are  mediated  through the 
CDC31 gene. 
We  next  tested  the  genetic  interactions  between  the 
DSK2-1 and CDC31-16 suppressors of kar1A17. Although 
CDC31-16 is a  dominant suppressor of the temperature- 
sensitive kar1A17 mutation (Vallen et al., 1994), it is a re- 
cessive  temperature-sensitive  mutation  in  a  wild-type 
KARl+  background.  In  addition,  CDC31-16  causes  su- 
persensitivity to the dosage of wild-type KARl+,  even a 
single extra copy of KARl +  is toxic in a  CDC31-16 mu- 
tant.  When  DSK2-1  on  a  low copy plasmid  was  trans- 
formed into  a  CDC31-16  strain,  very few transformants 
were  obtained.  However,  many transfromants  were  ob- 
tained when the CDC31-16 mutant was transformed by ei- 
ther the plasmid vector or a low copy plasmid containing 
DSK2+. Furthermore, many transformants were obtained 
when an equivalent  amount of the DSK2-1  plasmid was 
transformed into the CDC31  wild-type strain. Therefore, 
the DSK2-1 allele was toxic in the presence of the CDC31- 
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tant  strain.  Indirect  immunofluorescence was  performed  on  a 
karl  deletion strain kept alive  by the DSK2-1  suppressor.  The 
anti-Cdc31p staining (B) corresponds to the anti-90-kD staining 
(C) on the nucleus as determined by DAPI staining (A). 
16  allele,  in  the  same  fashion  as  increased  dosages  of 
KARl + (Vallen et al., 1994). We also tested the toxicity of 
DSK2-1  to other cdc31 mutant alleles and found that it is 
toxic to cdc31-2 but not to cdc31-1  or cdc31-5.  Strikingly, 
the  CDC31-16  and  cdc31-2  alleles  both  map  to  the 
COOH-terminus of Cdc31p, a region previously identified 
as critical to CDC31 suppression of karlA17 (Vallen et al., 
1994). DSK2-1  did not suppress the temperature  sensitiv- 
ity of any of the cdc31 mutants, supporting the hypothesis 
that Cdc31p acts downstream of Dsk2p. 
Dsk2p Is a Nuclear-enriched Protein 
Since DSK2-1 restores Cdc31p localization to the SPB in a 
karl deletion, we wanted to determine whether it is a SPB 
component  that  interacts  with  Cdc31p.  Affinity-purified 
anti-Dsk2p antibodies were used for indirect immunofluo- 
rescence  on wild-type  and  dsk2A  strains.  DAPI staining 
was used to visualize the nucleus, and anti-tubulin staining 
was  used  to  visualize  the  microtubules.  Cells  were  pro- 
cessed  by both formaldehyde fixation and the methanol- 
acetone method of Rout and Kilmartin (1990) and showed 
the same result. Dsk2p staining appeared to be nuclear en- 
riched  (Fig.  11 A, right),  as determined  by colocalization 
with the DAPI staining in wild-type cells (Fig. 11 A, mid- 
dle) and the lack of staining in the dsk2 deletion cells (Fig. 
11  B,  right)  In  addition,  there  is  a  cytoplasmic  pool  of 
Dsk2p.  That  the  nuclear  staining  was  not  due  to 
bleedthrough  of the DAPI staining was demonstrated by 
performing  anti-Dsk2p  staining  without  DAPI  staining 
(data  not  shown).  To  determine  if  the  localization  of 
Dsk2-1p might be different than the wild-type protein, in- 
direct  immunofluorescence  was  also  performed  on  a 
DSK2-1  strain.  Like the wild-type protein, Dsk2-1p was a 
nuclear protein (data not shown). 
To determine  whether  Dsk2p  might be  a  SPB compo- 
nent that is not detectable by immunofluorescence due to 
the large nuclear pool of Dsk2p, a  Western blot was per- 
formed on partially purified SPBs. Equal amounts of each 
fraction of the purification (see Materials and Methods for 
details) were Western blotted with anti-Dsk2p (Fig. 11 D) 
and anti-Cdc31p (Fig. 11 C) antibodies. The Dsk2 protein 
appeared enriched in the nuclear fraction (Fig. 11 D, lanes 
6  and  7),  but  it  was not detectable  in  the  SPB  fractions 
(Fig. 11 D, lanes 12 and 13). However, Cdc31p, a compo- 
nent  of the  SPB  (Spang  et  al.,  1993;  Biggins  and  Rose, 
1994), was detectable in both the nuclear (Fig. 11 C, lanes 
6 and 7) and SPB fractions (Fig. 11 C, lanes 12 and 13). We 
Figure 11.  Dsk2 is a nuclear-enriched protein. (A and B) Indirect 
immunofluorescence was performed on wild-type (A) and dsk2A 
(B) strains using affinity-purified anti-Dsk2p antibodies. Nomar- 
ski optics are shown in the left panels, DAPI staining in the mid- 
dle  panels,  and  anti-Dsk2p  staining  in  the  righthand  panels. 
Dsk2p stains the entire cell and is enriched in the nucleus as de- 
termined by the increased staining that corresponds to the DAPI 
staining.  This staining is not present in the dsk2A strain,  indicat- 
ing it is specific to the Dsk2p protein. (C and D) Western blots on 
partially purified SPBs. Western blots using anti-Cdc31p (C) and 
anti-Dsk2p (D) were performed on partially purified SPBs. The 
fraction numbers of gradients from the purification are indicated 
above the blots. Yeast spheroplasts were prepared and lysed (ly- 
sate is shown lane 1). A crude nuclear pellet,  (pellet,  lane 3; su- 
pernatant, lane 2) was loaded onto a gradient of layers 2.0, 2.1, 
and 2.3 M sucrose-polyvinylpyrolidone. The fractions from this 
gradient are: lane 4 (sample layer), lane 5 (sample layer/2.01 M), 
lane 6 (2.01/2.1 M), lane 7 (2.1/2.3 M), and lane 8 (2.3 M). The nu- 
clei from the 2.1/2.3 fraction were collected and lysed, and SPBs 
were subsequently enriched on a second sucrose gradient (lanes 
9-13). The fractions from this gradient are: lane 9 (sample layer), 
lane 10 (sample layer/1.75 M), lane 11 (1.75/2 M), lane 12 (2/2.25 M), 
and lane 13 (2.25/2.5 M). The nuclei are present in fractions 6 and 
7, nuclear envelope is in fractions 9 and 10, and the SPBs are in 
fractions  12  and  13.  Cdc31p is  enriched  in the  SPB  fractions, 
while Dsk2p is enriched in nuclei but not in SPBs. Total yeast ly- 
sate as a control for antibody staining is shown in lane 14. 
conclude that Dsk2p is a  nuclear-enriched  protein that is 
probably not a component of the SPB. 
Discussion 
Dsk2 Is a  Ubiquitin-like Protein 
We cloned the DSK2  suppressor  of kar1A17 by suppres- 
sion of the temperature-sensitive  defect and found it en- 
codes  a  novel  ubiquitin-like  protein  containing  an  NH2- 
terminal  domain  homologous  to  ubiquitin  and  a  novel 
COOH-terminal domain. Ubiquitin-like proteins have been 
identified  in  many  other  organisms,  such  as  the  human 
BAT2  and  BAT3  genes  in  the  major  histocompatibility 
complex (Banerji et al., 1990). However, although numer- 
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mechanism of action remains unknown. 
We determined that like Rad23p, the NH2-terminal do- 
main of Dsk2p is not cleaved from the protein. Therefore, 
Dsk2p  cannot  be  posttranslationally conjugated  to  sub- 
strate proteins like ubiquitin to cause substrate degrada- 
tion  or modification.  Since the  DSK2  suppressor  muta- 
tions  mapped  to  the  ubiquitin-like  domain,  we  tested 
whether this domain was sufficient for DSK2 suppression 
of kar1A17. Although the ubiquitin-like domains were ex- 
pressed  at  levels  comparable  to  the  full-length  protein 
(data not shown), neither the DSK2+ nor DSK2-1 ub-like 
domain could suppress karlA17.  Therefore, unlike ubiq- 
uitin, the  COOH-terminal domain of Dsk2p  is  required 
for protein function. 
The  DSK2-1  and  DSK2-2  suppressor  mutations  of 
karlA17 both changed amino acid 69 from histidine to ty- 
rosine  in the  ubiquitin-like  domain.  This residue, which 
corresponds to amino acid 68 in ubiquitin, is conserved in 
ubiquitin  and is important for the proteasomal degrada- 
tion of polyubiquitinated substrates (Ecker et al., 1987). In 
a previous study, a mutation in this residue in ubiquitin de- 
creased the proteolysis rate of substrates to 30%  of wild 
type  (Ecker et  al.,  1987).  Dsk2p  and  Cdc31p  have  ex- 
tremely long half-lives, and the DSK2-1 mutation did not 
alter the stability of these proteins. In addition, we could 
not detect ubiquitinated forms of either Cdc31p or Dsk2p 
(data not shown), indicating that these proteins probably 
are not degraded by the ubiquitin pathway. Therefore, if 
the DSK2-1 mutation alters proteolysis, it must change the 
stability of an unknown protein. 
DSK2 Is Involved in SPB Duplication 
Since a dsk2 deletion has no obvious phenotype, we tested 
whether  this  is  due  to  functional  redundancy  with  the 
other ubiquitin-like gene in yeast, RAD23,  originally iso- 
lated in a screen for UV-sensitive mutants. A  dsk2 rad23 
double deletion strain is temperature sensitive due to a de- 
fect in SPB duplication. In contrast to the karlzal7 allele, 
which is defective for the maintenance of Cdc31p localiza- 
tion at the SPB (Biggins and Rose, 1994), Cdc31p was still 
localized at the single SPB. However, since CDC31-16 and 
high copy CDC31 + can suppress the temperature sensitiv- 
ity of rad23za  dsk2A, their function must be mediated in 
concert with Cdc31p. In addition, since CDC31 alleles sup- 
press the dsk2za  rad23A  strain  and  DSK2  alleles cannot 
suppress  cdc31  mutants,  CDC31  must  function  down- 
stream of these genes for SPB duplication. 
Unlike the rad23 mutant, the dsk2A does not exhibit UV 
sensitivity. In  addition,  in  a  dsk2  tad23  double deletion 
strain, UV sensitivity was equivalent to rad23za, so it is un- 
likely that they share functional redundancy for DNA re- 
pair.  Therefore, we  propose  that  the  two  known  yeast 
ubiquitin-like  proteins  are  involved in  SPB  duplication, 
and RAD23 has an additional role in DNA repair. 
In addition to the defect in SPB duplication when dsk2 
and  tad23  are deleted, we found that  overexpression of 
DSK2 and DSK2-1 causes toxicity. The overexpression of 
DSK2+ causes cells to accumulate with short bipolar spin- 
dles,  while overexpression of DSK2-1  causes  a  block in 
SPB duplication. Therefore, the overexpression of the mu- 
tant DSK2-1 causes an earlier cell cycle block than overex- 
pression of wild-type DSK2. Since neither loss of function 
nor gain of function dsk2 mutants lead to a perfectly uni- 
form arrest in the cell cycle, Rad23p/Dsk2p may have mul- 
tiple  roles  throughout  the  cell cycle. This  hypothesis  is 
consistent  with  the  finding  that  wild-type  and  DSK2-1 
overexpression block at different stages. 
The overexpression of KARl +  (Rose and Fink,  1987) 
also causes toxicity when overexpressed, probably due to 
the formation of a large aggregate that contains Karlp and 
Cdc31p  (Biggins  and  Rose,  1994).  Although  overex- 
pressed Dsk2p forms aggregates throughout the cell, we 
could not detect the presence of Cdc31p in these aggre- 
gates  (data not shown).  Therefore, although we did not 
determine the mechanism by which overexpression causes 
a block in SPB duplication, the dosage of DSK2 is critical 
for accurate SPB duplication. 
Models for DSK2 Suppression of karl 
Like the CDC31 suppressors of karlA17, the DSK2-1 sup- 
pressor restores the localization of Cdc31p to the SPB in a 
karl mutant. Dsk2-1p may relocalize Cdc31p to the SPB 
by either directly physically interacting with Cdc31p or by 
indirectly assisting Cdc31p localization. Although Dsk2p is 
a  nuclear  protein, it  might  transiently interact with  the 
SPB to localize the Cdc31 protein. We used several tech- 
niques to determine whether Dsk2p and Cdc31p interact 
physically. First, no binding was observed in a gel overlay 
assay in which radiolabeled Cdc31p was used to probe im- 
mobilized bacterial and yeast Dsk2p  and Dsk2-1p  (data 
not  shown;  Biggins  and  Rose,  1994).  Second,  Dsk2p, 
Dsk2-1p, and Cdc31p did not coimmunoprecipitate from 
yeast. Finally, Dsk2p and Cdc31p did not coaggregate in 
vivo into a complex formed by overexpression of Dsk2p 
(data not shown). Therefore, Dsk2p and Cdc31p may tran- 
siently interact in vivo but probably do not form a stable 
complex. 
We previously proposed that  CDC31  suppressors may 
bypass KARl  function due to increased interaction with 
another unknown protein (Vallen et al., 1994; Biggins and 
Rose, 1994).  Here we showed that DSK2 function is not 
required for CDC31-16 to suppress karlA17.  However, a 
kar1A17 dsk2A  rad23A  strain  is  very temperature sensi- 
tive, indicating  that  these  three genes  affect a  common 
function.  Because  both  CDC31-16  and  high  copy 
CDC31+  can suppress the temperature sensitivity of this 
strain, the karlza17 dsk2A rad23A strain is specifically de- 
fective for CDC31  function. Furthermore, neither Dsk2p 
nor  Rad23p  are  required  for  Cdc31p  suppression  of 
karlA17. Therefore, as is the case for KARl, CDC31 gene 
function must be downstream of DSK2, and there must be 
at least one additional factor with which Cdc31p suppres- 
sors show an altered interaction to suppress karl  muta- 
tions. The CDC31-16  allele is sensitive to the dosage of 
DSK2-1, just as it is sensitive to the dosage of KARl+. In 
addition, DSK2-1  is  also toxic to the cdc31-2  allele,  an- 
other  COOH-terminal  cdc31  mutation.  This  region was 
previously determined to be critical to the CDC31 mecha- 
nism of karlza17 suppression (Vallen et al., 1994).  There- 
fore, CDC31 is sensitive to the dosage of DSK2, suggest- 
ing  some  type  of  interaction  between  the  DSK2  and 
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DSK2 mediates most of its functions through CDC31. 
Dsk2p is a novel ubiquitin-like protein that has a role in 
SPB  duplication.  The  DSK2-1  suppressor  exhibits  many 
phenotypes similar to the KARl  gene  and can relocalize 
Cdc31p to the SPB in a karl deletion strain. Since Dsk2p is 
a nuclear-enriched protein that acts upstream of CDC31 in 
the SPB duplication pathway, we propose that Dsk2p may 
have  a  chaperone-like  role  similar  to  Rad23p  and  assist 
Cdc31p assembly into a new SPB. Since the dsk2A rad23A 
strain that blocks SPB  duplication  at 37°C did  not affect 
the localization of Cdc31p at the sole SPB, DSK2 function 
may not affect the  old  SPB.  Therefore,  we propose  that 
Dsk2p  is  involved  in  the  assembly  of  a  new  SPB,  and 
Rad23p  may be either directly involved in this process or 
else be able to functionally substitute for Dsk2p. 
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